Markets:

Overview

News

Currencies

International

Treasuries

Femasys Inc. - Common Stock (NQ:FEMY)

0.4010 -0.0287 (-6.68%)

Streaming Delayed Price Updated: 1:02 PM EDT, Apr 7, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Femasys Inc. - Common Stock

< Previous 1 2

...

4 5 6 7 8 9 10 11 Next >

Why Carnival Shares Are Trading Lower By 9%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

June 26, 2023

Gainers Benitec Biopharma Inc. (NASDAQ: BNTC) climbed 104% to $0.4050 after the company announced it received FDA clearance of the IND for BB-301 for the treatment of Oculopharyngeal Muscular...

Via Benzinga

Why Femasys Shares Are On The Move Monday ↗

June 26, 2023

Femasys Inc (NASDAQ: FEMY) shares are trading higher Monday after the company announced that it received an Investigational Device Exemption (IDE) approval from the FDA to evaluate FemBloc

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

June 26, 2023

Via Benzinga

Chardan Capital Maintains Buy Rating for Femasys: Here's What You Need To Know ↗

March 31, 2023

Via Benzinga

Femasys's Return On Capital Employed Overview ↗

March 31, 2023

Via Benzinga

Looking Into Femasys's Return On Capital Employed ↗

December 20, 2022

Via Benzinga

Femasys Announces FDA Approval of its IDE for the Pivotal Clinical Trial of FemBloc Permanent Birth Control, a Non-Surgical Alternative for Women

June 26, 2023

From Femasys Inc.

Via GlobeNewswire

Femasys Inc. Replaces Two Board Members with Seasoned Industry Leaders in the Life Sciences

June 15, 2023

From Femasys Inc.

Via GlobeNewswire

Femasys to Participate in the Healthcare Virtual Conference Presented by Maxim Group LLC and hosted by M-Vest on June 20-22, 2023

June 14, 2023

From Femasys Inc.

Via GlobeNewswire

Femasys’ FemCath Intrauterine Catheter Receives Product Approval in Canada

June 08, 2023

From Femasys Inc.

Via GlobeNewswire

Femasys Inc. Announces Financial Results for the First Quarter Ended March 31, 2023

May 11, 2023

From Femasys Inc.

Via GlobeNewswire

Femasys Inc. to Showcase Four Products at the American College of Obstetricians and Gynecologists Annual Clinic & Scientific Meeting

May 11, 2023

From Femasys Inc.

Via GlobeNewswire

Femasys’ FemCerv Endocervical Tissue Sampler for Cervical Cancer Diagnosis Receives Product Approval in Canada

May 03, 2023

From Femasys Inc.

Via GlobeNewswire

Femasys Inc. to Showcase FemCerv at the Annual Meeting for the American Society for Colposcopy and Cervical Pathology

May 01, 2023

From Femasys Inc.

Via GlobeNewswire

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

April 24, 2023

Via Benzinga

Nasdaq Edges Higher; Abbott Laboratories Reports Upbeat Results ↗

April 19, 2023

U.S. stocks traded mixed toward the end of trading, with the Nasdaq Composite turning higher on Wednesday. The Dow traded down 0.23% to 33,899.20 while the NASDAQ rose 0.16% to 12,172.92. The S&P 500,...

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

April 19, 2023

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

April 19, 2023

Via Benzinga

Why Travelers Companies Shares Are Trading Higher By Over 5%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

April 19, 2023

Gainers China Jo-Jo Drugstores, Inc. (NASDAQ: CJJD) gained 85.2% to $1.25 after the company announced the termination of its previously proposed registered direct offering.

Via Benzinga

Femasys Announces $3.9 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

April 19, 2023

From Femasys Inc.

Via GlobeNewswire

Femasys’ FemaSeed Localized Directional Insemination for Infertility Receives Product Approval in Canada

April 18, 2023

From Femasys Inc.

Via GlobeNewswire

Femasys Inc. Announces Financial Results for the Year Ended December 31, 2022 and Provides Corporate Update

March 30, 2023

From Femasys Inc.

Via GlobeNewswire

Femasys Inc. to Participate in “The Post-Roe Fertility Journey” Panel Discussion at SXSW 2023

March 09, 2023

From Femasys Inc.

Via GlobeNewswire

12 Health Care Stocks Moving In Friday's Intraday Session ↗

December 30, 2022

Via Benzinga

Why Titan Machinery Shares Are Trading Lower By Around 18%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

March 16, 2023

Gainers Lipella Pharmaceuticals Inc. (NASDAQ: LIPO) shares jumped 40.2% to $2.5109 after the company announced the successful completion of a Phase 2A clinical trial evaluating the safety and efficacy...

Via Benzinga

Exxon Mobil To Rally Around 19%? Here Are 5 Other Price Target Changes For Friday ↗

November 11, 2022

Via Benzinga

Femasys Inc. Announces Financial Results for the Third Quarter Ended September 30, 2022 and Provides Corporate Update

November 10, 2022

From Femasys Inc.

Via GlobeNewswire

Why New Oriental Education Shares Jumped Over 28%; Here Are 68 Biggest Movers From Yesterday ↗

October 27, 2022

Gainers ESSA Pharma Inc. (NASDAQ: EPIX) shares climbed 180.2% to close at $4.82 on Wednesday after the company highlighted updates results from the Phase 1/2 study of EPI-7386 with Enzalutamide At the...

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

October 26, 2022

Gainers

Via Benzinga

Why Seagate Shares Are Trading Lower By More Than 7%? Here Are 49 Stocks Moving In Wednesday's Mid-Day Session ↗

October 26, 2022

Gainers ESSA Pharma Inc. (NASDAQ: EPIX) shares surged 59.3% to $2.7417 after the company highlighted updates results from the Phase 1/2 study of EPI-7386 with Enzalutamide At the 29th Annual Prostate...

Via Benzinga

< Previous 1 2

...

4 5 6 7 8 9 10 11 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.